Ignite Creation Date:
2024-10-25 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06539208
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
A Phase IIIaOpen-label Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy ATTR-PN or Transthyretin Amyloidosis Cardiomyopathy ATTR-CM
Sponsor:
None
Organization:
None
Organization Data
Organization:
None
Class:
None
Study ID:
None
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
None
Lead Sponsor Class:
None
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None